Torben P. Frandsen
"MEDITECH" Limited Liability Company (LLC)
Torben P. Frandsen has more than 15 years experience from Pharma and Biotech industry. Dr. Frandsen has held different scientific and managerial positions at Symphogen and is now responsible for all of the CMC activities. Before joining Symphogen Dr. Frandsen held different scientific positions at NovozymesA/S and Santaris Pharma A/S. Dr. Frandsen has extensive experience with process development, manufacturing, release, and characterization of biological therapeutics including the regulatory review process. Dr. Frandsen has authored more than 30 peer reviewed publications.